PreprintAll rights reservedbioRxiv
Caenorhabditis elegans as a Model to Dissect Pharmacokinetic and Pharmacodynamic Relationships of Gabapentinoids
- 1Universite de Montreal
Related
- Clinical pharmacokinetic-pharmacodynamic relationships between drug exposure and the QT/QTc interval: Protocol for a systematic review and quantitative synthesis
- Distinct host responses to whole-cell and CFS effects of Clostridium perfringens in Caenorhabditis elegans
- Metabolic outsourcing from ingested lactic acid bacteria extends Caenorhabditis elegans healthspan via bacterial amino acid and enzyme provision
- Linking formulation composition to pharmacokinetic and pharmacodynamic responses: a predictive framework for sustained-release tablets
- Pharmacokinetic/pharmacodynamic evaluation of multidose oritavancin for prolonged durations of therapy
BibTeX
@misc{sultana2026caenorhabditis,
title = {{Caenorhabditis elegans as a Model to Dissect Pharmacokinetic and Pharmacodynamic Relationships of Gabapentinoids}},
author = {J. Sultana and J. D. Castano and J. R. E. del Castillo and F. Beaudry},
howpublished = {bioRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.26.747285},
url = {https://www.biorxiv.org/content/10.64898/2026.08.26.747285v1},
}
RIS
TY - UNPB
TI - Caenorhabditis elegans as a Model to Dissect Pharmacokinetic and Pharmacodynamic Relationships of Gabapentinoids
AU - J. Sultana
AU - J. D. Castano
AU - J. R. E. del Castillo
AU - F. Beaudry
PY - 2026
DA - 2026/08/26
PB - bioRxiv
DO - 10.64898/2026.08.26.747285
UR - https://www.biorxiv.org/content/10.64898/2026.08.26.747285v1
ER -